Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-625-7 | CAS number: 3164-85-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- Species:
- other: animal and human data
Additional information
- all available proprietary studies from the Metal carboxylates REACH Consortium (MCRC)
- detailed literature searches in online databases
- screening of human health review articles
- rigorous quality and reliability screening according to Klimisch criteria, where those criteria apply
Introduction to read-across matrix
A comprehensive data gap analysis was conducted for the entire substance portfolio of the Metal carboxylates REACH Consortium (MCRC), covering 10 metal carboxylates in total. This literature screening effort included:
During the literature search and data gap analysis it became obvious that the overall database on substance-specific human health hazard data for the metal carboxylates is too scant to cover all REACH endpoints. Therefore, the remaining data gaps had to be covered by either experimental testing or read-across from similar substances.
Selected endpoints for the human health hazard assessment are addressed by read-across, using a combination of data on the organic acid counterion and the metal (or one of its readily soluble salts). This way forward is acceptable, since metal carboxylates dissociate to the organic anion and the metal cation upon dissolution in aqueous media. No indications of complexation or masking of the metal ion through the organic acid were apparent during the water solubility tests (please refer to the water solubility data in section of the IUCLID and chapter of the CSR). Once the individual constituents of the metal carboxylate become bioavailable (i.e. in the acidic environment in the gastric passage or after phagocytosis by pulmonary macrophages), the “overall” toxicity of the dissociated metal carboxylate can be described by the toxicity of the “individual” constituents. Since synergistic effects are not expected for this group of metal carboxylates, the human health hazard assessment consists of an individual assessment of the metal cation and the organic anion.
The hazard information of the individual constituents was obtained from existing REACH registration dossiers via a license-to-use obtained by the lead registrant. These registration dossiers were submitted to ECHA in 2010 as full registration dossiers, and are thus considered to contain relevant and reliable information for all human health endpoints. All lead-registrant dossiers were checked for completeness and accepted by ECHA, i.e. a registration number was assigned.
Potassium 2-ethylhexanoate is the potassium metal salt of 2-ethylhexanoic acid, which readily dissociates to the corresponding monovalent potassium cation and 2-ethylhexanoic acid anions. The potassium cation and the 2-ethylhexanoic acid anion are considered to represent the overall toxicity of the potassium 2-ethylhexanoate in a manner proportionate to the free acid and the metal (represented by one of its readily soluble salts). Based on the above information, unrestricted read-across is considered feasible and justified.
Although the term „constituent“ within the REACH context is defined as substance (also being part of a mixture), the term constituent within this hazard assessment is meant to describe either part of the metal carboxylate salt, i.e. anion or cation.
Toxicity for reproduction – effects on fertility
No toxicity data on adverse effects on sexual function and fertility with potassium 2-ethylhexanoate are available, thus the reproductive toxicity will be addressed with existing data on the dissociation products as detailed in the table below. Further details on the genetic toxicity of the individual constituents are given below.
Table: Summary of toxicity data on adverse effects on sexual function and fertility of potassium 2-ethylhexanoate and the individual constituents.
|
potassium substances |
2-ethylhexanoic acid (CAS# 149-57-5) |
Potassium 2-ethylhexanoate (CAS# 3164-85-0) |
Two-generation reproductive toxicity study |
not reprotoxic (weight of evidence, human data) not classified |
NOAEL(rat; F1)
not classified |
no data
not classified |
Potassium
There is no evidence of any reprotoxic for potassium compounds. Potassium is abundantly available in the environment and in food, and is extensively distributed throughout the human body, which is contradictory to allegation of reprotoxic potential.
According to EFSA (2005) "the average dietary intake of potassium according to European food consumption studies is in the range of 3000 to 4000 mg/day." Furthermore, the publication states that [r]ecommended daily intakes in Europe are in the order of 3.1-3.5 g/day (SCF, 1993). The US Food and Nutrition Board have set an intake of 4.7 g potassium per day from food as an adequate intake, mainly based on the beneficial effects on blood pressure (FNB, 2004)" Lastly, EFSA (2005) reports that "the concentration of potassium in plasma is tightly regulated within a narrow range of about 3.5 to 5 mmol/L. The body is able to accommodate a high intake of potassium, without any substantial change in plasma concentration by synchronized alterations in both renal and extra-renal handling, with potassium either being excreted in the urine or taken up into cells. Thus the plasma or extracellular concentration of potassium does not give a clear indication of the body content of potassium (EFSA 2005)." Potential for fertility impairment of the abundantly available essential element potassium can be safely excluded.
2-Ethylhexanoic acid
2-Ethylhexanoic acid was administered via drinking water to an unspecified number of male and female rats at 0, 100, 300, or 600 mg/kg bw/day. There were no deaths. The relative epididymal weights in high-dose males were significantly increased, but no histological changes were noted. A slight, but not statistically significant increase in the number of abnormal sperm was noted in the highest two dose groups; however, the incidence per animal was not provided. Treated groups required more time to successfully complete mating, and the mean litter size in high-dose pregnant females was significantly reduced. The mean pup weights in the high-dose group were significantly lower on postnatal day 7 and 14. Mean fetal weight per litter and mean placental weights were significantly reduced in the mid- and high-dose groups. Clubfoot was the only skeletal malformation; changes in skeletal variations were also noted (wavy ribs, reduced cranial ossification, and twisted hind legs). Corrected maternal body weights at termination and weight gains of high-dose females were significantly reduced. Physical development of the eyes, teeth and hair appeared to be slightly later in the pups from the high-dose groups; the significance of this finding is unclear since no data were presented on the length of gestation in treated and control dams. The high-dose of 600 mg/kg bw/day significantly reduced overall water consumption and body weights in female animals. The NOAEL for reproductive effects in parental animals was 300 mg/kg bw/day; this effect occurred in the presence of maternal toxicity. The NOAEL for F1 offspring was 100 mg/kg bw/day. Based on these results, 2-ethylhexanoic acid is not likely to cause effects on fertility but is likely to be a developmental toxicant. The developmental toxicity of 2-ethylhexanoic acid is at least partially related to disruption of Zn metabolism and distribution in the mother, and that higher zinc levels in the mothers leads to lower developmental toxicity in offspring.
Potassium 2-ethylhexanoate
Since notoxicity data on adverse effects on sexual function and fertilityis available for potassium 2-ethylhexanoate, information on the individual constituents potassium and 2-ethylhexanoic acid will be used for the hazard assessment and, when applicable, for the risk characterisation of potassium 2-ethylhexanoate. For the purpose of hazard assessment of potassium 2-ethylhexanoate, the point of departure for the most sensitive endpoint of each constituent will be used for the DNEL derivation.
Short description of key information:
Potassium 2-ethylhexanoate is not expected to be toxic for reproduction.
Justification for selection of Effect on fertility via oral route:
Information from read-across substances:
human data for potassium: not reprotoxic
animal data for 2-ethylhexanoic acid: NOAEL(rat, P)=300mg/kg bw/day
Effects on developmental toxicity
Description of key information
Potassium 2-ethylhexanoate is expected to be a developmental toxicant.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- Species:
- other: animal and human data
Additional information
- all available proprietary studies from the Metal carboxylates REACH Consortium (MCRC)
- detailed literature searches in online databases
- screening of human health review articles
- rigorous quality and reliability screening according to Klimisch criteria, where those criteria apply
Introduction to read-across matrix
A comprehensive data gap analysis was conducted for the entire substance portfolio of the Metal carboxylates REACH Consortium (MCRC), covering 10 metal carboxylates in total. This literature screening effort included:
During the literature search and data gap analysis it became obvious that the overall database on substance-specific human health hazard data for the metal carboxylates is too scant to cover all REACH endpoints. Therefore, the remaining data gaps had to be covered by either experimental testing or read-across from similar substances.
Selected endpoints for the human health hazard assessment are addressed by read-across, using a combination of data on the organic acid counterion and the metal (or one of its readily soluble salts). This way forward is acceptable, since metal carboxylates dissociate to the organic anion and the metal cation upon dissolution in aqueous media. No indications of complexation or masking of the metal ion through the organic acid were apparent during the water solubility tests (please refer to the water solubility data in section of the IUCLID and chapter of the CSR). Once the individual constituents of the metal carboxylate become bioavailable (i.e. in the acidic environment in the gastric passage or after phagocytosis by pulmonary macrophages), the “overall” toxicity of the dissociated metal carboxylate can be described by the toxicity of the “individual” constituents. Since synergistic effects are not expected for this group of metal carboxylates, the human health hazard assessment consists of an individual assessment of the metal cation and the organic anion.
The hazard information of the individual constituents was obtained from existing REACH registration dossiers via a license-to-use obtained by the lead registrant. These registration dossiers were submitted to ECHA in 2010 as full registration dossiers, and are thus considered to contain relevant and reliable information for all human health endpoints. All lead-registrant dossiers were checked for completeness and accepted by ECHA, i.e. a registration number was assigned.
Potassium 2-ethylhexanoate is the potassium metal salt of 2-ethylhexanoic acid, which readily dissociates to the corresponding monovalent potassium cation and 2-ethylhexanoic acid anions. The potassium cation and the 2-ethylhexanoic acid anion are considered to represent the overall toxicity of the potassium 2-ethylhexanoate in a manner proportionate to the free acid and the metal (represented by one of its readily soluble salts). Based on the above information, unrestricted read-across is considered feasible and justified.
Although the term „constituent“ within the REACH context is defined as substance (also being part of a mixture), the term constituent within this hazard assessment is meant to describe either part of the metal carboxylate salt, i.e. anion or cation.
Toxicity for reproduction – developmental toxicity
No toxicity data on adverse effects on development of the offspring with potassium 2-ethylhexanoate are available, thus the reproductive toxicity will be addressed with existing data on the dissociation products as detailed in the table below. Further details on the genetic toxicity of the individual constituents are given below.
Table: Summary of toxicity data on adverse effects on development of the offspring of potassium 2-ethylhexanoate and the individual constituents.
|
potassium substances |
2-ethylhexanoic acid (CAS# 149-57-5) |
Potassium 2-ethylhexanoate (CAS# 3164-85-0) |
Pre-natal developmental toxicity study |
not reprotoxic (weight of evidence, human data) not classified
|
NOAEL(rat; mat.)= 250 mg/kg
NOAEL(rat; dev)= 100 mg/kg*
Category 2, H361d (CLP) Category 3, R63 (DSD) |
no data
self-classified, Category 3, R63 (DSD) |
Two-generation reproductive toxicity study |
not reprotoxic (weight of evidence, human data) not classified |
NOAEL(rat; F1)
not classified |
no data
not classified |
* Identified as most sensitive endpoint in the registration dossier for 2-ethylhexanoic acid, i.e. has been used for the DNEL derivation of this substance.
Potassium
There is no evidence of any reprotoxic for potassium compounds. Potassium is abundantly available in the environment and in food, and is extensively distributed throughout the human body, which is contradictory to allegation of reprotoxic potential.
According to EFSA (2005) "the average dietary intake of potassium according to European food consumption studies is in the range of 3000 to 4000 mg/day." Furthermore, the publication states that [r]ecommended daily intakes in Europe are in the order of 3.1-3.5 g/day (SCF, 1993). The US Food and Nutrition Board have set an intake of 4.7 g potassium per day from food as an adequate intake, mainly based on the beneficial effects on blood pressure (FNB, 2004)" Lastly, EFSA (2005) reports that "the concentration of potassium in plasma is tightly regulated within a narrow range of about 3.5 to 5 mmol/L. The body is able to accommodate a high intake of potassium, without any substantial change in plasma concentration by synchronized alterations in both renal and extra-renal handling, with potassium either being excreted in the urine or taken up into cells. Thus the plasma or extracellular concentration of potassium does not give a clear indication of the body content of potassium (EFSA 2005)." Potential for developmental toxicity of the abundantly available essential element potassium can be safely excluded.
2-Ethylhexanoic acid
2-Ethylhexanoic acid was administered via drinking water to an unspecified number of male and female rats at 0, 100, 300, or 600 mg/kg bw/day. There were no deaths. The relative epididymal weights in high-dose males were significantly increased, but no histological changes were noted. A slight, but not statistically significant increase in the number of abnormal sperm was noted in the highest two dose groups; however, the incidence per animal was not provided. Treated groups required more time to successfully complete mating, and the mean litter size in high-dose pregnant females was significantly reduced. The mean pup weights in the high-dose group were significantly lower on postnatal day 7 and 14. Mean fetal weight per litter and mean placental weights were significantly reduced in the mid- and high-dose groups. Clubfoot was the only skeletal malformation; changes in skeletal variations were also noted (wavy ribs, reduced cranial ossification, and twisted hind legs). Corrected maternal body weights at termination and weight gains of high-dose females were significantly reduced. Physical development of the eyes, teeth and hair appeared to be slightly later in the pups from the high-dose groups; the significance of this finding is unclear since no data were presented on the length of gestation in treated and control dams. The high-dose of 600 mg/kg bw/day significantly reduced overall water consumption and body weights in female animals. The NOAEL for reproductive effects in parental animals was 300 mg/kg bw/day; this effect occurred in the presence of maternal toxicity. The NOAEL for F1 offspring was 100 mg/kg bw/day. Based on these results, 2-ethylhexanoic acid is not likely to cause effects on fertility but is likely to be a developmental toxicant. The developmental toxicity of 2-ethylhexanoic acid is at least partially related to disruption of Zn metabolism and distribution in the mother, and that higher zinc levels in the mothers leads to lower developmental toxicity in offspring.
Potassium 2-ethylhexanoate
Since notoxicity data on adverse effects on development of the offspringis available for potassium 2-ethylhexanoate, information on the individual constituents potassium and 2-ethylhexanoic acid will be used for the hazard assessment and, when applicable, for the risk characterisation of potassium 2-ethylhexanoate. For the purpose of hazard assessment of potassium 2-ethylhexanoate, the point of departure for the most sensitive endpoint of each constituent will be used for the DNEL derivation. In case of 2-ethylhexanoic acid in potassium 2-ethylhexanoate, the NOAEL of 100 mg/kg bw/day for the reproductive toxicity in the F1 offspring will be used.
Considering the read-across principles as detailed above for potassium 2-ethylhexanoate based on the toxicological assessment of the individual constituents, the harmonised legally binding classification of 2-ethylhexanoic acid for reproductive toxicity is read-across to potassium 2-ethylhexanoate. Thus, potassium 2-ethylhexanoate is self-classified for reproductive toxicity in category 2 H361d (Suspected of damaging the unborn child) and according to Regulation 67/548/EEC in category 3 R63 (Possible risk of harm to the unborn child).
Justification for selection of Effect on developmental toxicity: via oral route:
Information from read-across substances:
human data for potassium:not reprotoxic
animal data for 2-ethylhexanoic acid: NOAEL(rat, F1)=100mg/kg bw/day
Justification for classification or non-classification
Considering the read-across principles as detailed above for potassium 2-ethylhexanoate based on the toxicological assessment of the individual constituents, the harmonised legally binding classification of 2-ethylhexanoic acid for reproductive toxicity is read-across to potassium 2-ethylhexanoate. Thus, potassium 2-ethylhexanoate is self-classified for reproductive toxicity in category 2 H361d (Suspected of damaging the unborn child) and according to Regulation 67/548/EEC in category 3 R63 (Possible risk of harm to the unborn child).
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
